Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Adverse event reports|
|Full bibliographic reference||Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards RI, Fernandez AM, Freedman SB, Goldsmith DI, Huang K, Jones JK, McLeay R, Moore N, Stather RH, Trenque T, Troutman WG, van Puijenbroek E, Williams F, Wise RP; International Society of Pharmacoepidemiology; International Society of Pharmacovigilance. Guidelines for submitting adverse event reports for publication.
Drug Saf. 2007;30(5):367-373. PMID: 17472416
Pharmacoepidemiol Drug Saf. 2007;16(5):581-587. PMID: 17471601
|Study design||Observational studies|
|Clinical area||Pharmaceutical medicine|
|Applies to the whole report or to individual sections of the report?||Harms/adverse effects/safety data|
|Record last updated on||August 16, 2016|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.
For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.
Visit our Help page for information about searching for reporting guidelines and for general information about using our website.